Ropes & Gray advised Biocare Medical, a global leader in clinical pathology, in its sale to Agilent Technologies Inc., in an all-cash transaction valued at $950 million. The definitive agreement, announced in a March 9 press release, will expand Agilent’s pathology portfolio through the addition of a highly complementary antibody, reagent and instrument business.
Biocare serves customers with a complementary portfolio of immunohistochemistry (IHC), in situ hybridization (ISH) and fluorescence in situ hybridization (FISH) solutions designed to support improved patient health outcomes across oncology and broader clinical pathology.
The Ropes & Gray team includes private equity partners Tim Castelli and Andrew Pomranke, litigation & enforcement partners Zak Goodwin and Ruchit Patel, tax partner Elaine Murphy, employment partner Jen Cormier and private equity counsel Raxit Shah.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.